Skip to content
Companies

Orthomod

Composite biomaterial implants for cervical spine fusion

Raised to date

No sales reported yet

of $2M offered across 1 Form D filing

Still open
$2M
Last filed
May 29, 2026

About

Orthomod LLC is a Dayton, Ohio medical device company developing structural orthopedic biomaterials and implants for musculoskeletal applications. Its core technology, CAMP (calcium-acrylic modified polymer), is a composite of an acrylic polymer with synthetic beta-tricalcium phosphate and hydroxyapatite that combines natural and synthetic orthobiologics with polymer components. In 2026 the company received FDA 510(k) clearance for the MOD-C cervical intervertebral implant family for degenerative disc disease of the cervical spine (C2-T1), with a clinical launch planned for the second half of 2026. The company targets spine, sports medicine, dental, trauma, and oncology applications.

CAMP is positioned as a third-generation implant material and an alternative to the titanium and PEEK that dominate spinal implants — microporous and hydrophilic like natural bone, enabling ionic transfer at the implant interface while providing immediate structural support and improved radiographic visibility.

Funding

  • EquityFiled May 29, 2026Form D
    None sold/ $2M

Product

MOD-C Cervical Implant

Spinal implant

An FDA-cleared cervical intervertebral body fusion device family for treating degenerative disc disease of the cervical spine from C2-T1, built from the company's CAMP biomaterial and scheduled for clinical launch in the second half of 2026.

  • FDA 510(k) cleared for degenerative disc disease of the cervical spine (C2-T1)
  • Built from CAMP calcium-acrylic modified polymer composite
  • Microporous, hydrophilic structure similar to natural bone

Built for

Spine and orthopedic surgeons, hospitals, and surgical centers performing cervical fusion and other musculoskeletal reconstruction

People on file